Systemic hypertension is the foremost constituent of Metabolic syndrome, involving various cardiovascular risk factors. Dual burden of hypertension and metabolic syndrome principally targets the heart. Commonest forms of organ damage among such patients includes hypertrophy and ventricular mass enlargement of left ventricle. This in turn is foremost risk factor to atrial fibrillation, systolic or diastolic failure of heart so may lead to sudden death. Study was carried out to determine left ventricular mass in patients those with metabolic and non metabolic syndrome. Total 150 subjects satisfying inclusions criteria were included in this study. Metabolic Syndrome was observed in 67 (44.67%). Among the metabolic syndrome patients,13(19.40%) had normal left ventricular mass,18(26.86%) had mild,16(23.88%) had moderate, and 20(29.85%) had severe Left ventricular mass. Mean Left ventricular mass among hypertensives with and without metabolic syndrome (208.52 and 171.98 respectively) was seen which is statistically significant. Metabolic syndrome has significant role for development of Left ventricular hypertrophy. Metabolic syndrome adds to the severity of hypertension related cardiac changes. Early screening of cardio metabolic risk factors among hypertensives and its treatment alleviate cardiovascular risk.

Systemic hypertension; Metabolic syndrome; Echocardiography; Left ventricular hypertrophy; Left ventricular mass